alpha1-Antitrypsin issu du plasma humain, poudre lyophilisée sans sel

Code: a6150-100mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Serine protease inhibitor; inhibits trypsin, chymotrypsin and pancreatic and granulocytic elastase, and acrosin. Effective concentration equimolar wit...


en savoir plus

Votre prix
£880.00 100MG
£1,056.00 inc. VAT

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Serine protease inhibitor; inhibits trypsin, chymotrypsin and pancreatic and granulocytic elastase, and acrosin. Effective concentration equimolar with proteinase.The effects of hereditary α1-antitrypsin deficiency and certain autoimmune states result from uncontrolled proteolysis in vivo. Direct α1-antitrypsin replacement therapy has shown promise in animal models of Type 1 diabetes.

≤10 mg will inhibit 1.0 mg of trypsin with activity of 10,000 BAEE units per mg protein. ≤10 mg will inhibit approx. 1.0 mg of ·α-chymotrypsin with activity of 40-50 BTEE units per mg protein.

Caution

Aqueous stock solutions containing 0.01% NaN3 are stable for several months. Solutions can be stored at −80 °C, but should not be refrozen. Unstable below pH 5.5. Inactivated by some non-serine proteinases and by oxidation of active site methionine residue.

Packaging

25, 100, 500 mg in glass bottle

Preparation Note

Chromatographically prepared and partially purified.

assay≥60% (biuret)
biological sourcehuman plasma
formsalt-free, lyophilized powder
Gene Informationhuman ... ELA2(1991), ELANE(1991), SERPINA1(5265)
Quality Level200
storage temp.2-8°C
technique(s)inhibition assay: suitable
UniProt accession no.P08246, P01009
Code
Description
Unité de vente
Prix annoncé
Qté
A6150-25MG
Unité:25MG
Prix annoncé: £238.00
Source:Prix annoncé
A6150-500MG
Unité:500MG
Prix annoncé: £3,960.00
Source:Prix annoncé
Cas Number9041-92-3
Ce produit répond aux critères suivants: